Previous close | 25.59 |
Open | 25.68 |
Bid | 25.78 x 0 |
Ask | 26.18 x 0 |
Day's range | 25.63 - 25.81 |
52-week range | 24.90 - 37.60 |
Volume | |
Avg. volume | 1 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CHARLOTTE, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences. William Blair 44th Annual Growth Stock Conference on June 5, 2024, at 9:20 am CT (10:20 am ET)Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, at 8:00 am ET Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors sec
CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on July 12, 2024, to holders of record as of June 28, 2024. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a cen
Net sales of $953 million decreased (2.6%), organic sales decreased (1.9%)GAAP gross margin of 53.1%, GAAP net income of $18 million or $0.09 per shareAdjusted EBITDA margin of 16.8%, adjusted EPS of $0.42Maintaining FY24 outlook for organic sales and adjusted EPS, trending towards the low-end of both ranges; reported sales adjusted for additional foreign currency impactCompany expects to repurchase up to $150 million of its common stock in Q2 2024 CHARLOTTE, N.C, May 02, 2024 (GLOBE NEWSWIRE) -